2015 ACR/EULAR 통풍 분류
용도사용 시기: structured classification after ≥1 symptomatic peripheral joint/bursa episode.
층별Classifies vs not — still not a standalone clinical diagnosis.
한계사용하지 않을 때: without entry criterion, or to force ULT decisions alone. · 함정: forgetting negative SF (−2) or very low urate (−4). · Septic arthritis must be excluded clinically when indicated.
출처中华医学会风湿病学分会痛风诊疗规范 on zh
이번 교대 다음 단계
점수 후: 장면 연산·인접 점수·대응 경로. 로컬 참고만 — HIS 기록 없음.
방법론 · 대입 예시·가이드라인 요점·상세
적용 상황
사용 시기: structured classification after ≥1 symptomatic peripheral joint/bursa episode.
입력 항목
- ≥1 episode swelling/pain/tenderness in a peripheral joint or bursa
- MSU crystals in symptomatic joint/bursa or tophus (sufficient)
- Joint/bursa pattern (highest ever)
- Episode characteristics count (erythema / can't bear touch / can't use joint)
- Typical time-course episodes (≥2 of: max pain <24h, resolve ≤14d, complete intercritical resolution)
- Clinical tophus
- Serum urate (highest, ideally off ULT)
- Synovial fluid of symptomatic joint MSU-negative
- Imaging urate deposition (US double-contour or DECT)
- Radiographic gout-related erosion (hands/feet)
계산 방법과 공식
MSU in symptomatic joint/tophus = sufficient. Else sum domains (pattern, characteristics, time-course, tophus, urate, SF−2, imaging urate, erosion); ≥8 classifies.
Score highest category ever within each hierarchical domain; use highest urate off ULT when possible.
계산 예시 (수치 대입)
아래 수치는 본 도구의 입력 항목에 정의된 예시값이며, 이 페이지의 공식으로 서버에서 실제 계산한 결과입니다. 계산 과정을 빠르게 확인할 수 있습니다. 대입 방법을 보여주는 예시일 뿐이며 임상적 조언이 아니고 실제 사례도 아닙니다.
| ≥1 episode swelling/pain/tenderness in a peripheral joint or bursa | No |
|---|---|
| MSU crystals in symptomatic joint/bursa or tophus (sufficient) | No / not demonstrated |
| Joint/bursa pattern (highest ever) | Ankle or midfoot mono/oligo without 1st MTP (1) |
| Episode characteristics count (erythema / can't bear touch / can't use joint) | One (1) |
| Typical time-course episodes (≥2 of: max pain <24h, resolve ≤14d, complete intercritical resolution) | One typical episode (1) |
| Clinical tophus | No (0) |
| Serum urate (highest, ideally off ULT) | 6–<8 mg/dL (2) |
| Synovial fluid of symptomatic joint MSU-negative | Not done / not negative (0) |
| Imaging urate deposition (US double-contour or DECT) | Absent / not done (0) |
| Radiographic gout-related erosion (hands/feet) | Absent / not done (0) |
→ACR/EULAR GoutNot applicable
- Entry:Requires ≥1 peripheral joint/bursa symptomatic episode.
| ≥1 episode swelling/pain/tenderness in a peripheral joint or bursa | Yes (required) |
|---|---|
| MSU crystals in symptomatic joint/bursa or tophus (sufficient) | Yes — sufficient for classification |
| Joint/bursa pattern (highest ever) | 1st MTP mono/oligo (2) |
| Episode characteristics count (erythema / can't bear touch / can't use joint) | Three (3) |
| Typical time-course episodes (≥2 of: max pain <24h, resolve ≤14d, complete intercritical resolution) | Recurrent typical episodes (2) |
| Clinical tophus | Yes (4) |
| Serum urate (highest, ideally off ULT) | ≥10 mg/dL (4) |
| Synovial fluid of symptomatic joint MSU-negative | MSU-negative (−2) |
| Imaging urate deposition (US double-contour or DECT) | Present (4) |
| Radiographic gout-related erosion (hands/feet) | Present (4) |
→ACR/EULAR GoutClassifies (MSU sufficient)
- Pathway:Sufficient criterion met — score not required
결과 판독과 층별
Classifies vs not — still not a standalone clinical diagnosis.
가이드라인 요점 (자체 정리)
- Entry gate + MSU sufficient pathway.
- ≥8 classifies.
- 다음: gout flare pathway; CN gout guideline on zh.
이상은 해당 가이드라인의 요점을 본 사이트가 자체 정리한 것이며, 원문 인용이 아닙니다.
주의점과 한계
- 사용하지 않을 때: without entry criterion, or to force ULT decisions alone.
- 함정: forgetting negative SF (−2) or very low urate (−4).
- Septic arthritis must be excluded clinically when indicated.
검증과 출처 · 거버넌스
참고 가이드라인과 출처
- [가이드라인 / 주요 출처]中华医学会风湿病学分会痛风诊疗规范 on zh
- Neogi T, et al. Arthritis Rheumatol / Ann Rheum Dis 2015 · 출처 ↗
자주 묻는 질문
자주 묻는 질문
- 2015 ACR/EULAR 통풍 분류은 환자 데이터를 업로드합니까? 어디서 계산합니까?
- 계산은 브라우저에서 로컬로 수행되며 입력과 결과는 서버로 업로드되지 않습니다. 면허 의사 참고용이며 병력·검사·소속 기관 프로토콜과 함께 해석해야 하고, 진단이나 처방을 대체하지 않습니다.
- 2015 ACR/EULAR 통풍 분류은 실제로 어떻게 계산합니까? 계산 예시를 보여줄 수 있습니까?
- 대입값: ≥1 episode swelling/pain/tenderness in a peripheral joint or bursa No, MSU crystals in symptomatic joint/bursa or tophus (sufficient) No / not demonstrated, Joint/bursa pattern (highest ever) Ankle or midfoot mono/oligo without 1st MTP (1), Episode characteristics count (erythema / can't bear touch / can't use joint) One (1), Typical time-course episodes (≥2 of: max pain <24h, resolve ≤14d, complete intercritical resolution) One typical episode (1), Clinical tophus No (0), Serum urate (highest, ideally off ULT) 6–<8 mg/dL (2), Synovial fluid of symptomatic joint MSU-negative Not done / not negative (0)… → 결과: ACR/EULAR Gout Not applicable(Entry: Requires ≥1 peripheral joint/bursa symptomatic episode.) 대입값: ≥1 episode swelling/pain/tenderness in a peripheral joint or bursa Yes (required), MSU crystals in symptomatic joint/bursa or tophus (sufficient) Yes — sufficient for classification, Joint/bursa pattern (highest ever) 1st MTP mono/oligo (2), Episode characteristics count (erythema / can't bear touch / can't use joint) Three (3), Typical time-course episodes (≥2 of: max pain <24h, resolve ≤14d, complete intercritical resolution) Recurrent typical episodes (2), Clinical tophus Yes (4), Serum urate (highest, ideally off ULT) ≥10 mg/dL (4), Synovial fluid of symptomatic joint MSU-negative MSU-negative (−2)… → 결과: ACR/EULAR Gout Classifies (MSU sufficient)(Pathway: Sufficient criterion met — score not required)
검증 절차
검증과 근거
본 도구의 공식과 계산 방법은 이 페이지에 명시되어 있으며 공개적으로 대조할 수 있습니다. 공식·계수·임계값은 위 권위 출처에 따라 대조했습니다.